Tag: QLOSI™

Presbyopia is a natural, age-related condition affecting 128 million worldwide, often addressed  with traditional solutions like reading glasses or progressive lenses. However, a groundbreaking  alternative is emerging: QLOSI™, a new presbyopia treatment featuring a 0.4% pilocarpine  hydrochloride ophthalmic solution.